Amino acid metabolic pathways are influenced by the NC1 POM cycle over expression. حسب Bonnie A. McNeil (22331601)

Targeting of Vps34 reduces B16F10 tumor growth and working model for Vps34-dependent regulation of eTreg transitional heterogeneity and maintenance. حسب Erienne G. Norton (9612079)

supplementary figure: Osimertinib inhibits the MYLK4-mediated phosphorylation of CDKAL1 to suppress stemness and chemoresistance in rhabdomyosarcoma حسب Takuto Itano (16830105)

"…(right): Self-renewal capacity of RD and AD-RD cells assessed by a sphere formation assay (n = 4). Statistical significance: ****p < 0.0001. c (top): Immunoblots from in vitro kinase assays treated with hit compounds and with EGFR inhibitors. …"